Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.8B | 6.4B | 6.3B | 6.6B |
Cost of revenue | 5.3B | 4.8B | 4.8B | 5.1B |
Gross profit | 1.4B | 1.5B | 1.5B | 1.5B |
Operating expense | ||||
Research & development | 125.8M | 128.2M | 104.9M | 92.6M |
Selling general and admin | 456.8M | 469.2M | 441.2M | 441.8M |
Other operating expenses | — | — | — | — |
Operating income | 852.6M | 935.7M | 917.4M | 968.9M |
Non operating interest income | ||||
Income | 31.5M | 32.9M | 36.1M | 38.6M |
Expense | 15.0M | 16.0M | 18.9M | 14.4M |
Other income expense | — | — | — | — |
Pretax income | 839.6M | 934.8M | 940.1M | 961.7M |
Tax provision | 187.9M | 262.9M | 235.2M | 207.6M |
Net income | 651.7M | 671.9M | 704.8M | 754.1M |
Basic EPS | 2.4 | 2.4 | — | 2.8 |
Diluted EPS | 2.3 | 2.3 | — | 2.6 |
Basic average shares | 276.2M | 276.5M | — | 272.2M |
Diluted average shares | 289.7M | 288.4M | — | 286.7M |
EBITDA | 959.5M | 1.1B | 1.1B | 1.1B |
Net income from continuing op. | 839.6M | 934.8M | 940.1M | 961.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |